Skip to main content
Premium Trial:

Request an Annual Quote

Finnzymes and Sage Science to Develop for Upstream and Downstream Analysis of PCR and qPCR Apps

This article updates an earlier version that incorrectly reported that the companies are co-developing PCR instruments.
 
NEW YORK (GenomeWeb News) — Finnzymes Instruments yesterday said it plans to use “core competencies” from Sage Science to develop a line of programmable instruments to be used in “key processes upstream and downstream analysis of PCR and qPCR applications.”
Finnzymes vice president of operations Mike Mortillaro said the company expects the new line of products will “complement” Finnzymes’ line of thermal cyclers and its expected real-time PCR instruments.
 
Financial terms of the agreement were not released.